These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
8. Macular and choroidal thickness after intracameral moxifloxacin for prevention of postcataract endophthalmitis. Ferreira BG; Cardoso da Silva I; Mélega MV; Nascimento MA; Cavalcanti Lira RP; Leite Arieta CE; Alves M J Cataract Refract Surg; 2021 Jan; 47(1):40-45. PubMed ID: 32818353 [TBL] [Abstract][Full Text] [Related]
9. Prophylactic intracameral cefazolin and postoperative topical moxifloxacin after cataract surgery: endophthalmitis risk reduction and safety results in a 16-year study. Moser CL; Lecumberri Lopez M; Garat M; Martín-Baranera M Graefes Arch Clin Exp Ophthalmol; 2019 Oct; 257(10):2185-2191. PubMed ID: 31392416 [TBL] [Abstract][Full Text] [Related]
10. Evaluation of the safety of prophylactic intracameral moxifloxacin in cataract surgery. Lane SS; Osher RH; Masket S; Belani S J Cataract Refract Surg; 2008 Sep; 34(9):1451-9. PubMed ID: 18721703 [TBL] [Abstract][Full Text] [Related]
11. Safety and efficacy of intracameral moxifloxacin injection for prophylaxis of endophthalmitis after phacoemulsification. Vieira IV; Boianovsky C; Saraiva TJ; Godoy RB; Lake J Arq Bras Oftalmol; 2017 Jun; 80(3):165-167. PubMed ID: 28832735 [TBL] [Abstract][Full Text] [Related]
12. Endophthalmitis Prophylaxis Study, Report 2: Intracameral antibiotic prophylaxis with or without postoperative topical antibiotic in cataract surgery. Rathi VM; Sharma S; Das T; Khanna RC Indian J Ophthalmol; 2020 Nov; 68(11):2451-2455. PubMed ID: 33120637 [TBL] [Abstract][Full Text] [Related]
13. Comparative analysis of the safety and efficacy of intracameral cefuroxime, moxifloxacin and vancomycin at the end of cataract surgery: a meta-analysis. Bowen RC; Zhou AX; Bondalapati S; Lawyer TW; Snow KB; Evans PR; Bardsley T; McFarland M; Kliethermes M; Shi D; Mamalis CA; Greene T; Rudnisky CJ; Ambati BK Br J Ophthalmol; 2018 Sep; 102(9):1268-1276. PubMed ID: 29326317 [TBL] [Abstract][Full Text] [Related]
14. Safety of prophylactic intracameral moxifloxacin use in cataract surgery. Ekinci Koktekir B; Aslan BS J Ocul Pharmacol Ther; 2012 Jun; 28(3):278-82. PubMed ID: 22304496 [TBL] [Abstract][Full Text] [Related]
15. Endophthalmitis prophylaxis study. Report 1: Intracameral cefuroxime and moxifloxacin prophylaxis for the prevention of postcataract endophthalmitis in rural India. Rathi VM; Sharma S; Das T; Khanna RC Indian J Ophthalmol; 2020 May; 68(5):819-824. PubMed ID: 32317453 [TBL] [Abstract][Full Text] [Related]
16. Impact of prophylactic intracameral moxifloxacin on post-cataract surgery endophthalmitis: data from a tertiary eye care facility in rural India. Shenoy P; Goh EJH; Kashikar R; Kohli GM; Sachdeva M; Naman V; Sood D; Bhatia P; Sen P; Agrawal R; Sen A Int Ophthalmol; 2021 Aug; 41(8):2729-2736. PubMed ID: 33821388 [TBL] [Abstract][Full Text] [Related]